Related Experiment Videos
PANDORA - Survey of Brazilian cardiologists about cholesterol reduction
R D Santos1, A C Spósito, J E dos Santos
1Department of Atherosclerosis, Brazilian Society of Cardiology, São Paulo, SP, Brazil. rdsf@uol.com.br
Insights
Physicians understand dyslipidemia impacts coronary disease but show gaps in applying II Brazilian Guidelines Conference recommendations for atherosclerosis prevention, particularly LDL-C targets and diabetic care.
Area of Science:
- Cardiology
- Preventive Medicine
- Endocrinology
Background:
- Dyslipidemia is a key risk factor for atherosclerosis.
- The II Brazilian Guidelines Conference on Dyslipidemias established new lipid targets.
- Physician understanding of these guidelines is crucial for effective patient care.
Purpose of the Study:
- To assess physicians' comprehension of the II Brazilian Guidelines Conference on Dyslipidemias.
- To evaluate current practices in primary and secondary atherosclerosis prevention.
- To identify knowledge gaps regarding lipid targets and treatment strategies.
Main Methods:
- A questionnaire was administered to 746 physicians (98% cardiologists).
- The survey covered dyslipidemia, atherosclerosis prevention, and guideline-specific lipid targets.
- Data analysis focused on understanding and application of recommendations.
Main Results:
- Most physicians recognized dyslipidemia's impact on coronary disease.
- Adherence to total cholesterol recommendations was high, but LDL-C targets for secondary prevention were less understood (55.8%).
- Significant knowledge deficits were observed regarding HDL-C levels, long-term lipid-lowering drug use, treatment adjustments, and targets for diabetic patients.
Conclusions:
- Physicians acknowledge the importance of lipids in atherosclerosis prevention.
- Substantial deficiencies exist in physicians' knowledge of the II Brazilian Guidelines Conference on Dyslipidemias.
- Targeted education is needed to improve guideline adherence and patient outcomes.
Objective:
To report about a group of physicians' understanding of the recommendations of the II Brazilian Guidelines Conference on Dyslipidemias, and about the state of the art of primary and secondary prevention of atherosclerosis.
Methods:
Through the use of a questionnaire on dyslipidemia, atherosclerosis prevention, and recommendations for lipid targets established by the II Brazilian Guidelines Conference on Dyslipidemias, 746 physicians, 98% cardiologists, were evaluated.
Results:
Eighty-seven percent of the respondents stated that the treatment of dyslipidemia changes the natural history of coronary disease. Although most of the participants followed the total cholesterol recommendations (<200mg/dL for atherosclerosis prevention), only 55.8% would adopt the target of LDL-C <100 mg/dL for secondary prevention. Between 30.5 and 36.7% answered, in different questions, that the recommended level for HDL-C should be <35mg/dL. Only 32.7% would treat their patients indefinitely with lipid- lowering drugs. If the drug treatment did not reach the proposed target, only 35.5% would increase the dosage, and 29.4% would change the medication. Participants did not know the targets proposed for diabetics.
Conclusion:
Although the participating physicians valued the role played by lipids in the prevention of atherosclerosis, serious deficiencies exist in their knowledge of the recommendations given during the II Brazilian Guidelines Conference on Dyslipidemias.